Long-term risk of fibroid recurrence after laparoscopic myomectomy

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 180, Issue 1, 2014, Pages 35-39

  Radosa, M P ^a   Owsianowski, Z ^a   Mothes, A ^a   Weisheit, A ^a   Vorwergk, J ^a   Asskaryar, F A ^a   Camara, O ^a   Bernardi, T S ^a   Runnebaum, I B ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Laparoscopic myomectomy; Recurrence rate; Reproductive surgery; Symptomatic leiomyoma; Uterine fibroid

Indexed keywords

ADULT; AGE; ARTICLE; BODY MASS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FEMALE INFERTILITY; FISHER EXACT TEST; FOLLOW UP; HOSPITALIZATION; HUMAN; HYSTERECTOMY; LAPAROSCOPIC MYOMECTOMY; LAPAROSCOPIC SURGERY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MENORRHAGIA AND METRORRHAGIA; MYOMECTOMY; OPERATION DURATION; OUTCOME ASSESSMENT; PERINEAL PAIN; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; RISK FACTOR; TREATMENT INDICATION; TUMOR LOCALIZATION; TUMOR VOLUME; UTERUS CAVITY; UTERUS MYOMA; COHORT ANALYSIS; EPIDEMIOLOGY; LAPAROSCOPY; LEIOMYOMA; LEIOMYOMATOSIS; MIDDLE AGED; PATHOLOGY; TUMOR RECURRENCE; UTERINE NEOPLASMS;

ADULT; AGE FACTORS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LAPAROSCOPY; LEIOMYOMA; LEIOMYOMATOSIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS; TUMOR BURDEN; UTERINE MYOMECTOMY; UTERINE NEOPLASMS;

EID: 84922387398     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2014.05.029     Document Type: Article

References (37)

1. Arslan AA, Gold LI, Mittal K, et al. Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review. Hum Reprod 2005;20(4):852-63
2. Hafner N, Diebolder H, Jansen L, Hoppe I, Durst M, Runnebaum IB. Hypermethylated DAPK in serum DNA of women with uterine leiomyoma is a biomarker not restricted to cancer. Gynecol Oncol 2011;121(1):224-9
3. Jeon YT, Kim JW, Park NH, Song YS, Kang SB, Lee HP. DNA repair gene XRCC1 Arg399Gln polymorphism is associated with increased risk of uterine leiomyoma. Hum Reprod 2005;20(6):1586-9
4. Okolo S. Incidence, aetiology and epidemiology of uterine fibroids. Best Pract Res Clin Obstet Gynaecol 2008;22(4):571-88
5. Pitter MC, Gargiulo AR, Bonaventura LM, Lehman JS, Srouji SS. Pregnancy outcomes following robot-assisted myomectomy. Hum Reprod 2013;28 (1):99-108
6. Sizzi O, Rossetti A, et al. Italian multicenter study on complications of laparoscopic myomectomy. J Minim Invasive Gynecol 2007;14(4):453-62
7. Stringer NH, Walker JC, Meyer PM. Comparison of 49 laparoscopic myomectomies with 49 open myomectomies. J Am Assoc Gynecol Laparosc 1997;4(4):457-64
8. Candiani GB, Fedele L, Parazzini F, Villa L. Risk of recurrence after myomectomy. Br J Obstet Gynaecol 1991;98(4):385-9
9. Fedele L, Parazzini F, Luchini L, Mezzopane R, Tozzi L, Villa L. Recurrence of fibroids after myomectomy: a transvaginal ultrasonographic study. Hum Reprod 1995;10(7):1795-6
10. Yoo EH, Lee PI, Huh CY, et al. Predictors of leiomyoma recurrence after laparoscopic myomectomy. Minim Invasive Gynecol 2007;14(6):690-7
11. Doridot V, Dubuisson JB, Chapron C, Fauconnier A, Babaki-Fard K. Recurrence of leiomyomata after laparoscopic myomectomy. J Am Assoc Gynecol Laparosc 2001;8(4):495-500
12. NezhatFR,Roemisch M,NezhatCH,SeidmanDS,NezhatCR.Recurrencerateafter laparoscopic myomectomy. J Am Assoc Gynecol Laparosc 1998;5(3):237-40
13. Fauconnier A, Chapron C, Babaki-Fard K, Dubuisson JB. Recurrence of leiomyomata after myomectomy. Hum Reprod Update 2000;6(6):595-602
14. Jin C, Hu Y, Chen XC, et al. Laparoscopic versus open myomectomy-a meta-analysis of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol 2009;145(1):14-21
15. Altgassen C, Kuss S, Berger U, Loning M, Diedrich K, Schneider A. Complications in laparoscopic myomectomy. Surg Endosc 2006;20(4):614-8
16. Munroa MG, Critchley H, Broderd MS, Frasere IS. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet 2011;113(April (1)):3-13
17. Freeman GH, Halton. Note on an exact treatment of contingency, goodness of fit and other problems of significance. Biometrika 2014;38:141-9
18. Acien P, Quereda F. Abdominal myomectomy: results of a simple operative technique. Fertil Steril 1996;65(1):41-51
19. Finn WF, Muller PF. Abdominal myomectomy: special reference to subsequent pregnancy and to the reappearance of fibromyomas of the uterus. Am J Obstet Gynecol 1950;60(1):109-16
20. Seracchioli R, Manuzzi L, Vianello F, et al. Obstetric and delivery outcome of pregnancies achieved after laparoscopic myomectomy. Fertil Steril 2006;86 (1):159-65
21. Vercellini P, Maddalena S, De Giorgi O, Pesole A, Ferrari L, Crosignani PG. Determinants of reproductive outcome after abdominal myomectomy for infertility. Fertil Steril 1999;72(1):109-14
22. Hodge JC, Cuenco KT, Huyck KL, et al. Uterine leiomyomata and decreased height: a common HMGA2 predisposition allele. Hum Genet 2009;125 (3):257-63
23. Flake GP, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect 2003;111(8):1037-54
24. Marshall LM, Spiegelman D, Goldman MB, et al. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. Fertil Steril 1998;70(3):432-9
25. Matsuo H, Kurachi O, Shimomura Y, Samoto T, Maruo T. Molecular bases for the actions of ovarian sex steroids in the regulation of proliferation and apoptosis of human uterine leiomyoma. Oncology 1999;57(Suppl. 2):49-58
26. Andersen J. Growth factors and cytokines in uterine leiomyomas. Semin Reprod Endocrinol 1996;14(3):269-82
27. Brandon DD, Erickson TE, Keenan EJ, et al. Estrogen receptor gene expression in human uterine leiomyomata. J Clin Endocrinol Metab 1995;80(6):1876-81
28. Engman M, Granberg S, Williams AR, Meng CX, Lalitkumar PG, Gemzell-Danielsson K. Mifepristone for treatment of uterine leiomyoma. A prospective randomized placebo controlled trial. Hum Reprod 2009;24 (8):1870-9
29. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 2003;188(1):100-7
30. Cramer SF, Marchetti C, Freedman J, Padela A. Relationship of myoma cell size and menopausal status in small uterine leiomyomas. Arch Pathol Lab Med 2000;124(10):1448-53
31. Radosa MP, Winzer H, Mothes AR, et al. Laparoscopic myomectomy in peri-and post-menopausal women is safe, efficacious and associated with long-term patient satisfaction. Eur J Obstet Gynecol Reprod Biol 2012;162 (2):192-6
32. Tinelli A, Hurst BS, Mettler L, et al. Ultrasound evaluation of uterine healing after laparoscopic intracapsular myomectomy: an observational study. Hum Reprod 2012;27(9):2664-70
33. Parker WH. Uterine myomas: management. Fertil Steril 2007;88:255
34. Lefebvre G, Vilos G, Allaire C, et al. The management of uterine leiomyomas. J Obstet Gynaecol Can 2003;25:396
35. Fergusson D, Aaron SD, Guyatt G, Hebert P. Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis. Br Med J 2002;325:652-4
36. Dumville J, Torgerson J, Hewitt C. Reporting attrition in randomised controlled trials. Br Med J 2006;7547:969-71
37. Hayden JA, Cote P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 2006;144:427-37.